Qube Research & Technologies LTD Neogenomics Inc Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Neogenomics Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 61,218 shares of NEO stock, worth $918,882. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,218
Holding current value
$918,882
% of portfolio
0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$13.4 - $17.73 $820,321 - $1.09 Million
61,218 New
61,218 $902,000
Q1 2024

May 14, 2024
BUY
$14.06 - $16.79 $232,622 - $277,790
16,545 New
16,545 $260,000
Q3 2023

Nov 13, 2023
BUY
$12.15 - $17.85 $1.3 Million - $1.91 Million
106,781 Added 313.16%
140,879 $1.73 Million
Q2 2023

Aug 14, 2023
BUY
$14.1 - $19.83 $239,996 - $337,526
17,021 Added 99.67%
34,098 $547,000
Q1 2023

May 15, 2023
SELL
$9.09 - $19.45 $638,663 - $1.37 Million
-70,260 Reduced 80.45%
17,077 $297,000
Q4 2022

Feb 14, 2023
BUY
$6.45 - $12.07 $563,323 - $1.05 Million
87,337 New
87,337 $806,000
Q2 2022

Aug 15, 2022
SELL
$7.06 - $13.97 $135,919 - $268,950
-19,252 Closed
0 $0
Q1 2022

May 09, 2022
BUY
$12.15 - $35.28 $233,911 - $679,210
19,252 New
19,252 $234,000
Q2 2020

Aug 14, 2020
SELL
$24.21 - $31.02 $193,002 - $247,291
-7,972 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$20.5 - $34.53 $142,270 - $239,638
-6,940 Reduced 46.54%
7,972 $220,000
Q4 2019

Feb 13, 2020
BUY
$18.96 - $29.84 $282,731 - $444,974
14,912 New
14,912 $436,000

Others Institutions Holding NEO

# of Institutions
295
Shares Held
125M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.89B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email